The conversation covers how our understanding of obesity as a chronic, relapsing disease has changed over the past 30 years, what the new clinical versus preclinical obesity framework means for how we diagnose and treat it, how GLP-1 drugs work and why they've succeeded where earlier medications failed, what the STEP and SELECT trials revealed about the disease-modifying potential of semaglutide, and how patients and clinicians should be thinking about who these drugs are really for
Ozan Erdogan and Bilal Gl
If you specifically need brand-name medication, want built-in lifestyle coaching, or live in Mississippi or Louisiana, another platform will likely serve you better
The convergence of metabolic and inflammatory pathways suggests that GLP-1 RAs hold promise as an adjunctive therapy for IBD
With the card, Ozempic costs $499 a month for established patients who take 2 mg
Humans produce glutathione (called GSH) naturally, but less as we age